Genetic diversity in fluoroquinolone and macrolide-resistant Campylobacter coli from pigs.

[1]  F. Mégraud,et al.  Molecular basis of macrolide resistance in Campylobacter: role of efflux pumps and target mutations. , 2005, The Journal of antimicrobial chemotherapy.

[2]  K. Stärk,et al.  Clinical herd health, farm management and antimicrobial resistance in Campylobacter coli on finishing pig farms in Switzerland. , 2005, Preventive veterinary medicine.

[3]  S. Lévesque,et al.  Macrolide Resistance in Campylobacter jejuni and Campylobacter coli: Molecular Mechanism and Stability of the Resistance Phenotype , 2005, Antimicrobial Agents and Chemotherapy.

[4]  Johnnie A Yates.  Traveler's diarrhea. , 2005, American family physician.

[5]  T. Wassenaar,et al.  Genetic Diversity and Antibiotic Resistance Patterns in a Campylobacter Population Isolated from Poultry Farms in Switzerland , 2005, Applied and Environmental Microbiology.

[6]  O. Sahin,et al.  Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Butzler,et al.  Campylobacter, from obscurity to celebrity. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  T. Giger,et al.  Banning antimicrobial growth promoters in feedstuffs does not result in increased therapeutic use of antibiotics in medicated feed in pig farming , 2004, Pharmacoepidemiology and drug safety.

[9]  G. Klein,et al.  Analysis of gyrA mutations in quinolone‐resistant and ‐susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non‐radioactive single‐strand conformation polymorphism analysis and DNA sequencing , 2004, Journal of Applied Microbiology.

[10]  Shama Desai Ahuja,et al.  Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Stärk,et al.  Risk factors for antibiotic resistance in Campylobacter spp. isolated from raw poultry meat in Switzerland , 2003, BMC public health.

[12]  Qijing Zhang,et al.  Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness , 2003, Animal Health Research Reviews.

[13]  F. Mégraud,et al.  PCR-Restriction Fragment Length Polymorphism Analysis for Detection of Point Mutations Associated with Macrolide Resistance in Campylobacter spp , 2003, Antimicrobial Agents and Chemotherapy.

[14]  K. Stärk,et al.  Reduced antibiotic resistance to fluoroquinolones and streptomycin in ‘animalfriendly’ pig fattening farms in Switzerland , 2003, Veterinary Record.

[15]  N. Bharucha,et al.  BMC Public Health BioMed Central Research article Hypertension in the Parsi community of Bombay: a study on prevalence, awareness and compliance to treatment , 2002 .

[16]  O. Sahin,et al.  In Vivo Selection of Campylobacter Isolates with High Levels of Fluoroquinolone Resistance Associated with gyrA Mutations and the Function of the CmeABC Efflux Pump , 2003, Antimicrobial Agents and Chemotherapy.

[17]  B. Duim,et al.  Amplified Fragment Length Polymorphism Analysis ofCampylobacter jejuni Strains Isolated from Chickens and from Patients with Gastroenteritis or Guillain-Barré or Miller Fisher Syndrome , 2000, Applied and Environmental Microbiology.

[18]  G. Zirnstein,et al.  Ciprofloxacin Resistance in Campylobacter jejuniIsolates: Detection of gyrA Resistance Mutations by Mismatch Amplification Mutation Assay PCR and DNA Sequence Analysis , 1999, Journal of Clinical Microbiology.

[19]  D. Michael Olive,et al.  Principles and Applications of Methods for DNA-Based Typing of Microbial Organisms , 1999, Journal of Clinical Microbiology.

[20]  M. Blaser,et al.  Epidemiologic and clinical features of Campylobacter jejuni infections. , 1997, The Journal of infectious diseases.

[21]  I. Nachamkin,et al.  Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system , 1996, Journal of clinical microbiology.

[22]  W. M. Huang,et al.  Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of quinolone resistance mutations , 1993, Antimicrobial Agents and Chemotherapy.

[23]  V. Perreten.  Resistance in the Food Chain and in Bacteria from Animals: Relevance to Human Infections , 2005 .

[24]  L. Piddock,et al.  Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. , 2003, The Journal of antimicrobial chemotherapy.

[25]  C. Soussy,et al.  Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli. , 2001, Microbial drug resistance.

[26]  F. Aarestrup,et al.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. , 2001, Emerging infectious diseases.

[27]  T. Wassenaar,et al.  Variation of the flagellin gene locus of Campylobacter jejuni by recombination and horizontal gene transfer. , 1995, Microbiology.